New full dopamine D3 receptor agonist CJ-1639 displays potent and selective activity in vivo July 11, 2011
Titan Pharmaceuticals to begin unblinding and data analysis for confirmatory Probuphine trial July 7, 2011
ALXN-4100TPO counteracts effects of radiation by inducing hematopoietic recovery in vivo July 1, 2011
RSS